Analystreport

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.

Oncternal Therapeutics, Inc.  (ONCT) 
Last oncternal therapeutics, inc. earnings: 8/8 04:01 pm Check Earnings Report